首页> 外文期刊>Journal of tissue engineering and regenerative medicine >Decellularized pancreas as a native extracellular matrix scaffold for pancreatic islet seeding and culture
【24h】

Decellularized pancreas as a native extracellular matrix scaffold for pancreatic islet seeding and culture

机译:叶片胰腺作为胰岛种子和培养的天然细胞外基质支架

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Diabetes mellitus involves the loss of function and/or absolute numbers of insulin‐producing β cells in pancreatic islets. Islet transplantation is currently being investigated as a potential cure, and advances in tissue engineering methods can be used to improve pancreatic islets survival and functionality. Transplanted islets experience anoikis, hypoxia, and inflammation‐mediated immune response, leading to early damage and subsequent failure of the graft. Recent development in tissue engineering enables the use of decellularized organs as scaffolds for cell therapies. Decellularized pancreas could be a suitable scaffold as it can retain the native extracellular matrix and vasculature. In this study, mouse pancreata were decellularized by perfusion using 0.5% sodium dodecyl sulfate. Different characterizations revealed that the resulting matrix was free of cells and retained part of the pancreas extracellular matrix including the vasculature and its internal elastic basal lamina, the ducts with their basal membrane, and the glycosaminoglycan and collagen structures. Islets were infused into the ductal system of decellularized pancreata, and glucose‐stimulated insulin secretion results confirmed their functionality after 48?hr. Also, recellularizing the decellularized pancreas with green fluorescent protein‐tagged INS‐1 cells and culturing the system over 120?days confirmed the biocompatibility and non‐toxic nature of the scaffold. Green fluorescent protein‐tagged INS‐1 cells formed pseudoislets that were, over time, budding out of the decellularized pancreata. Decellularized pancreatic scaffolds seeded with endocrine pancreatic tissue could be a potential bioengineered organ for transplantation.
机译:摘要糖尿病是指胰岛中产生胰岛素的β细胞功能和/或绝对数量的丧失。目前,胰岛移植是一种潜在的治疗方法,组织工程方法的进步可用于改善胰岛的存活和功能。移植的胰岛会经历失巢、缺氧和炎症介导的免疫反应,导致早期损伤和随后的移植失败。组织工程的最新发展使脱细胞器官成为细胞治疗的支架。脱细胞胰腺可能是一种合适的支架,因为它可以保留天然的细胞外基质和血管系统。在这项研究中,使用0.5%的十二烷基硫酸钠对小鼠胰腺进行灌注脱细胞。不同的表征表明,生成的基质没有细胞,保留了部分胰腺细胞外基质,包括血管系统及其内部弹性基底层、导管及其基膜、糖胺聚糖和胶原结构。胰岛被注入去细胞胰腺的导管系统,葡萄糖刺激的胰岛素分泌结果证实了48小时后胰岛的功能?人力资源部。此外,用绿色荧光蛋白标记的INS-1细胞对脱细胞胰腺进行再细胞化,并在120℃以上培养该系统?days证实了支架的生物相容性和无毒性。绿色荧光蛋白标记的INS-1细胞形成假胰岛,随着时间的推移,假胰岛从脱细胞胰腺中发芽。脱细胞胰腺支架植入胰腺内分泌组织可能是一种潜在的生物工程器官移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号